ArticleBlood cancer journal2011

AV-65, a novel Wnt/β-catenin signal inhibitor, successfully suppresses progression of multiple myeloma in a mouse model.

H Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.